You are here

Ovarian Hormone Therapy for Women in the 21st Century

by Jerilynn C. Prior MD, FRCPC, ABIM, ABEM

My objective is go beyond cultural myths (such as “Estrogen is what makes a girl a girl” or “Estrogen is women’s elixir of youth”) to provide accurate information about what is normal in women’s reproductive lives. In the past many believed that all menopausal women needed “hormone replacement therapy”. The results of major randomized controlled trials such as the Women’s Health Initiative hormone studies show us that the pill estrogen (conjugated equine estrogen) alone or with progestin (a synthetic knock-off of natural progesterone) caused more harm than benefit. We also now know that estrogen with progestin increases breast cancer. Note: progesterone and progestin are totally different. Progestins only need to be proven to change the lining of the uterus and usually have many different cellular effects.  

The new concepts are: 1) menopause and its low hormone levels are normal; 2) progesterone is likely as effective, and safer than, estrogen for treating hot flushes/flashes and night sweats; 3) Ovarian Hormone Therapy (OHT) of estradiol and progesterone, or progesterone alone, in life phase-appropriate therapy can safely be used to restore a normal hormonal balance for symptomatic women.

Estrogen is really three hormones:

1. Estradiol: the ovarian hormone of the menstruating woman,

2. Estrone: the hormone of menopausal women, and

3. Estriol: the hormone of the pregnant woman.

Estradiol is the commonly available bio-identical hormone used for treatment.

Estradiol is only one part of women’s balanced hormonal system—we should always think of estradiol and progesterone (women’s other important reproductive hormone) together. Estradiol is an important hormone for young women’s health—it is a powerful growth stimulator causing cell proliferation in every tissue and also preventing bone loss. However, estradiol must be balanced by progesterone to be effective as well as safe.

Progesterone is the hormone of the second half of a menstrual cycle in which ovulation (egg release) has occurred. Progesterone is initially a growth-stimulator but then acts to slow growth while encouraging cells to mature and do their special jobs. Progesterone halts estrogen-related overgrowth. In bone—estrogen slows bone loss while progesterone promotes building of new bone and bone strength.

In perimenopause, the transition from regular menstrual cycles to menopause, estradiol levels are unpredictable and usually higher than in younger women; progesterone levels are lower and often absent. In menopause it is normal to have low estradiol and progesterone levels. Menopause is the life phase that begins one year after the last flow, or whenever both ovaries are surgically removed.          

Some general cautions about hormone therapy:

  1. Never take oral or pill-type estrogens. This form of estrogen causes risks for serious blood clots. Pills have no advantages over taking bio-identical estradiol absorbed through the skin (as a patch or gel).
  2. Never take estradiol alone, meaning without progesterone. A woman who has had a hysterectomy still has breasts, brain and bones that also need progesterone. Estradiol plus progesterone (in contrast to estrogen combined with progestins) is not associated with increased breast cancer risk in two large observational studies from France.

Effective & Safe Reasons for Ovarian Hormone Therapy

  1. Cyclic oral micronized progesterone (Prometrium or compounded) therapy for irregular or skipped cycles, heavy flow, acne or risks for osteoporosis in teens, young adult and perimenopausal women. Effective non-hormonal (barrier + spermicide or copper IUD) contraception is needed.
  2. Cyclic progesterone therapy (link in #1) for night sweats/hot flushes, premenstrual breast tenderness, fluid retention and mood swings in very early perimenopausal women with regular menstruation. (Non-hormonal birth control is needed).
  3. Estradiol (as a patch or gel) in normal menstrual cycle doses days 1-25 of the month with oral micronized progesterone 300 mg at bedtime days 14-27 of the month for early menopause1 year without flow and high FSH levels at age 40 or younger. Continue both until aged 52. Follow these instructions for stopping
  4. Estradiol (as a patch or gel) in normal menstrual cycle doses days 1-25 of the month with oral micronized progesterone 300 mg at bedtime days 14-27 of the month for menopause (1 year without flow) in a woman younger than 45 who has both a low bone density/or past fragility fracture plus hot flushes/flashes and night sweats disturbing sleep. Continue both for five years and follow link in #3 for instructions about stopping.
  5. Oral micronized progesterone 300 mg at bedtime daily for sleep-disturbing moderate-severe hot flushes/flashes and night sweats in a perimenopausal or menopausal women. Stop treatment once a year to see if the night sweats have gone away. If they have not ended, restart therapy.
  6. Oral micronized progesterone 300 mg at bedtime daily for three months in a young adult or perimenopausal woman with persistent heavy flow and low blood count/anemia. Transition to cyclic progesterone (see link in #1.)
  7. Oral micronized progesterone 300 mg at bedtime daily for a highly symptomatic perimenopausal woman who has classic migraine headaches and would otherwise take cyclic progesterone. Going on and off progesterone may trigger migraines.

Vaginal estriol cream 0.5 mg once a week applied by finger to the outer 1/3 of the vagina helps if vaginal discomfort with intercourse persists despite gentle and frequent sex while using non-hormonal lubricants.

Updated Date: 
May 22, 2015

Estrogen’s Storm Season: Stories of Perimenopause

Estrogen's Storm Season

by Dr. Jerilynn C Prior

New second edition available

Estrogen’s Storm Season is now available in BOTH print and eBook (Mobi and ePUB) versions!

All royalties are recieved in our Endowment fund (overseen by UBC) and support CeMCOR's research and future.

It is full of lively, realistic stories with which women can relate and evidence-based, empowering perimenopause information. It was a finalist in 2006 for the Independent Publisher Book Award in Health.

Purchase your ebook copy via our Amazon Kindle or
Google Play storefronts!

Paperback copies (with updated insert) still available here.

Join a Study:

Get Involved

Volunteer research participants are the heart of all CeMCOR research. Participants are invited to provide feedback on study processes, to learn their own results and at the end of a study, be the first to hear what the whole study found. Please become a CeMCOR research participant—you can contribute to improving the scientific information available for daughters, friends and the wider world of women.